249 related articles for article (PubMed ID: 3928685)
1. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
MacGregor LC; Matschinsky FM
J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
[TBL] [Abstract][Full Text] [Related]
2. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
3. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
4. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
5. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
6. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA
Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
8. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
10. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
[TBL] [Abstract][Full Text] [Related]
11. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
Greene DA; Chakrabarti S; Lattimer SA; Sima AA
J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
Goldfarb S; Simmons DA; Kern EF
Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
[No Abstract] [Full Text] [Related]
13. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium.
MacGregor LC; Matschinsky FM
Metabolism; 1986 Apr; 35(4 Suppl 1):28-34. PubMed ID: 3007925
[TBL] [Abstract][Full Text] [Related]
14. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
Cohen M
Diabet Med; 1985 May; 2(3):203-6. PubMed ID: 3032499
[No Abstract] [Full Text] [Related]
16. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
17. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
Greene DA; Mackway AM
Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
[TBL] [Abstract][Full Text] [Related]
18. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
Ono H; Nozawa Y; Hayano S
Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
[No Abstract] [Full Text] [Related]
19. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
20. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]